Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and
significantly impact on patients' quality of life, exacerbation frequency, and survival. There is …

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the
complete 2023 GOLD report, which can be freely downloaded from its web page (www …

Background: Pulmonary rehabilitation is recognized as a core component of the
management of individuals with chronic respiratory disease. Since the 2006 American …

Under-recognised and untreated depression and anxiety symptoms have deleterious effects
on physical functioning and social interaction increasing fatigue and healthcare utilisation in …

People with advanced chronic obstructive pulmonary disease (COPD) have distressing
physical and psychological symptoms, often have limited understanding of their disease …

Anxiety and depression are common and important comorbidities in patients with chronic
obstructive pulmonary disease (COPD). The pathophysiology of these psychological …

Chronic lung diseases are the third leading cause of death worldwide and are increasing in
prevalence over time. Although much of our traditional understanding of health and disease …

More than one third of individuals with chronic obstructive pulmonary disease (COPD)
experience comorbid symptoms of depression and anxiety. This review aims to provide an …

Chronic obstructive pulmonary disease (COPD), one of the most common chronic diseases
and a leading cause of death, has historically been considered a disease of men. However …